Genomics and Evolutionary Dynamics Group

Professor Trevor Graham's group harnesses artificial intelligence and the principles of evolution with the aim of improving cancer prevention, diagnosis and treatment.


Professor Trevor Graham

Director of the Centre for Evolution and Cancer:

Genomics and Evolutionary Dynamics Headshot of Trevor Graham

Trevor Graham is Professor of Genomics and Evolution and the Director of the Centre for Evolution and Cancer. Trevor’s interdisciplinary expertise is at the intersection between evolutionary theory, mathematical modelling, genomics and molecular pathology.

Researchers in this group

.

Phone: +44 20 3437 6874

Email: [email protected]

Location: Sutton

.

OrcID: 0000-0002-3966-3579

Email: [email protected]

Location: Sutton

.

Phone: +44 20 3437 6234

Email: [email protected]

Location: Sutton

I am a post-doctoral bioinformatician researching cancer evolution using genomics with a particular interest in chromosomal instability. I obtained my degree in Biochemistry at the University of Manchester and then my PhD at the Francis Crick Institute researching paediatric cancer evolution. As part of Professor Sottoriva's team, I am involved in multiple projects focusing on the evolutionary patterns of several adult cancers including breast, colon and prostate.

.

Email: [email protected]

Location: Sutton

.

Email: [email protected]

Location: Sutton

.

Phone: +44 20 3437 7210

Email: [email protected]

Location: Sutton

.

Phone: +44 20 3437 6216

Email: [email protected]

Location: Sutton

.

Phone: +44 20 3437 6872

Email: [email protected]

Location: Sutton

.

Phone: +44 20 3437 6021

Email: [email protected]

Location: Sutton

.

Phone: +44 20 3437 6338

Email: [email protected]

Location: Sutton

.

Phone: +44 20 3437 6875

Email: [email protected]

Location: Sutton

.

Phone: +44 20 3437 6386

Email: [email protected]

Location: Sutton

.

Email: [email protected]

Location: Chelsea

.

Phone: +44 20 8722 4693

Email: [email protected]

Location: Sutton

.

Email: [email protected]

Location: Sutton

.

Email: [email protected]

Location: Sutton

.

Phone: +44 20 3437 6240

Email: [email protected]

Location: Sutton

.

Phone: +44 20 3437 6094

Email: [email protected]

Location: Sutton

.

Email: [email protected]

Location: Sutton

.

Email: [email protected]

Location: Sutton

.

Email: [email protected]

Location: Sutton

Nick Trahearn profile picture .

Phone: +44 20 3437 6102

Email: [email protected]

Location: Sutton

.

Phone: +44 20 3437 6866

Email: [email protected]

Location: Sutton

.

Email: [email protected]

Location: Sutton

.

Phone: +44 20 3437 3522

Email: [email protected]

Location: Sutton

Recent discoveries from this group

Human colon cancer cells with the cell nuclei stained red and the protein E-cadherin stained green.

06/08/24

Cancers develop partly through genetic abnormalities within cells of the body. Colorectal cancer is a major cause of death worldwide, but we don’t yet have a full understanding of the genetic changes that cause it to grow. New research – published today in Nature – delivers an unprecedented view of the genetic landscape of CRC and its responses to treatment.
Prostate cancer cells treated with nano sized drug carriers

11/07/24

Combining the principles of evolution with artificial intelligence (AI), scientists have proposed a new way to predict the chance of prostate cancer returning. In a recent study, they harnessed computational methods to capture specific tumour measurements relating to the tumour’s ability to change over time. They then showed that these measurements correlate with disease recurrence more than a decade after the initial diagnosis.
T cell_547x410

14/03/24

Scientists have developed an improved technique for reading the genetic material associated with the body’s immune response to cancer, making it possible to study tissue samples that have been stored in archives for decades.
T cell_547x410

09/03/23

Scientists have developed a new way of using cancers’ DNA to spot cancer patients who may benefit from immunotherapy.